Related Experiment Video
Updated: Apr 25, 2026

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
The Development of the Novel Positron Emission Tomography Radiotracer for Selective HDAC8 Imaging
Yafei Huang1, Yongle Wang1, Yanli Wang1
1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States.
Abstract:
HDACs play important roles in various neurological disorders. Unlike other HDAC subtypes that have been extensively studied in neurodegenerative diseases, HDAC8 has only recently emerged as a regulator in the central nervous system. In this study, we designed and successfully radiosynthesized [11C]HYF031 as a potential HDAC8 radioligand with acceptable radiochemical yield and purity. In vitro autoradiography and self-blocking dynamic PET/CT studies in C57BL/6 mice demonstrated specific binding of [11C]HYF031 to HDAC proteins in the brain. Dynamic PET imaging further showed measurable brain uptake and pharmacokinetic properties compatible with PET imaging. Biodistribution studies indicated that the tracer is primarily metabolized through the hepatobiliary system. Overall, these results suggest that [11C]HYF031 is a promising lead tracer for HDAC8 imaging.
More Related Videos
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

